The Riley Hospital for Children at Indiana University Health is a nationally ranked freestanding 354-bed, pediatric acute care children's hospital in Indianapolis, Indiana, United States. It is affiliated with the Indiana University School of Medicine.

There are 354 beds in Riley Hospital for Children.

During the past decade, Riley Hospital for Children conducted 300 clinical trials. In the 10-year time frame, 300 clinical trials started and 195 clinical trials were completed, i.e. on average, 65% percent of trials that started reached the finish line to date. In the past 5 years, 136 clinical trials started and 100 clinical trials were completed. i.e. 73.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Riley Hospital for Children" #1 sponsor was "Children's Oncology Group" with 105 trials, followed by "National Cancer Institute (NCI)" with 78 trials sponsored, "Indiana University" with 57 trials sponsored, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 18 trials sponsored and "Eli Lilly and Company" with 18 trials sponsored. Other sponsors include 258 different institutions and companies that sponsored additional 135 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Riley Hospital for Children" #1 collaborator was "National Cancer Institute (NCI)" with 109 trials as a collaborator, "Cystic Fibrosis Foundation" with 26 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 20 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 18 trials as a collaborator and "Children's Oncology Group" with 13 trials as a collaborator. Other collaborators include 282 different institutions and companies that were collaborators in the rest 173 trials.

According to Clinical.Site data, the most researched conditions in "Riley Hospital for Children" are "Cystic Fibrosis" (48 trials), "Recurrent Malignant Solid Neoplasm" (28 trials), "Refractory Malignant Solid Neoplasm" (27 trials), "Recurrent Neuroblastoma" (26 trials) and "Recurrent Osteosarcoma" (23 trials). Many other conditions were trialed in "Riley Hospital for Children" in a lesser frequency.

Most popular intervention types in "Riley Hospital for Children" are "Drug" (343 trials), "Other" (170 trials), "Biological" (83 trials), "Procedure" (81 trials) and "Radiation" (46 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (80 trials), "Cyclophosphamide" (48 trials), "Pharmacological Study" (42 trials), "Vincristine Sulfate" (41 trials) and "Placebo" (36 trials). Other intervention names were less common.

The vast majority of trials in "Riley Hospital for Children" are 524 trials for "All" genders, 8 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Riley Hospital for Children". undefined are not yet recruiting, 119 are recruiting, 110 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 252 completed trials in Riley Hospital for Children, 5 suspended trials, and 31 terminated clinical trials to date.

Out of the total trials that were conducted in Riley Hospital for Children, 74 "Phase 1" clinical trials were conducted, 159 "Phase 2" clinical trials and 147 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 18 trials, and there were also 66 trials that are defined as “Not Applicable".

Riley Hospital for Children has several departments that took part in Clinical trials: "Riley Children Cancer Center at Riley Hospital for Children" - 21 trials, "James Whitcomb Riley Hospital for Children" - 14 trials, "Riley Child and Adolescent Psychiatry Clinic - Riley Hospital for Children" - 8 trials, "Riley Children's Specialties" - 2 trials, "IU Health Physicians - Riley Child Neurology" - 2 trials, "General Pediatrics Clinic Medical Service Area 1 in Riley Hospital for Children at IU Health" - 2 trials